Form 4 for BBIO BridgeBio Pharma, Inc.
Accepted 2023-04-07 00:00:00 ET · period of report 2023-04-05 · accession 0001209191-23-023808 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-04-07 | 2023-04-05 | BBIO | STEPHENSON BRIAN C | CFO, Sec, Treas | S - Sale | $15.45 | -55.5K | 101.3K | -35% | -$857.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-05 | S | D | 55,500 | $15.45 | 101,337 | D | — | — | (F2) Represents the weighted average sale price of the shares sold from $15.20 to $15.78 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote. |